benphothiamine has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caporali, A; Emanueli, C; Katare, RG; Madeddu, P; Meloni, M; Oikawa, A | 1 |
1 other study(ies) available for benphothiamine and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway.
Topics: Analysis of Variance; Animals; Apoptosis; Blood Flow Velocity; Blotting, Western; Carrier Proteins; Cells, Cultured; Chromones; Diabetes Mellitus, Experimental; Diastole; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibrosis; Heart Failure; Immunohistochemistry; Mice; Microfilament Proteins; Morpholines; Oxidative Stress; Proto-Oncogene Proteins c-pim-1; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Thiamine; Up-Regulation | 2010 |